October 2, 2008. The National Research Center for Women & Families’ position is that cough and cold products for children should not continue to be available OTC because they are generally ineffective and pose unnecessary safety risks to our children.
Read More »On Health Policy
Testimony to FDA Science Board on Bisphenol A (BPA) in Food Containers
September 16, 2008. BPA is used in a variety of products including reusable water bottles, baby bottles, and plastic tableware. Epoxy resins made with BPA are used to coat the insides of canned foods and beverages.
Read More »Letter to U.S. Senators and Reps. Urging Them to Include in the Final Consumer Product Safety Commission Reform Act the Senate Language that Eliminates Phthalates in Children’s Products and Childcare Articles
May 14, 2008. Banning phthalates in toys and children’s products will reduce potentially dangerous exposures that could harm children’s development and increase children’s risk of developing cancer and reproductive problems as adults.
Read More »Letter to Dr. Janet Woodcock (FDA), Expressing Concern about the Anti-Infective Drugs Advisory Committee (AIDAC) Meetingts Regarding Clinical Trial Designs for Antibiotic Treatments for Community-Acquired Pneumonia (CAP)
May 12, 2008. The undersigned members of the Patient and Consumer Coalition write to express our concerns about the April 1 and 2 meetings of the Anti-Infective Drugs Advisory Committee (AIDAC) regarding clinical trial designs for antibiotic treatments for community-acquired pneumonia (CAP).
Read More »NCHR Testimony at FDA Advisory Panel Meeting on LASIK Devices
April 25, 2008. The FDA’s mission is to ensure that medical products are safe and effective. For LASIK, it is essential that we remember that safe alternatives are less expensive and readily available: glasses and contact lenses.
Read More »